# Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

> **NCT00690235** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 33 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Diabetes
- Weight Gain

## Interventions

- **DRUG:** Pramlintide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00690235
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690235, "Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00690235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*